Advertisement
Advertisement
U.S. markets open in 4 hours 13 minutes
Advertisement
Advertisement
Advertisement
Advertisement

CTI BioPharma Corp. (CTIC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
5.53+0.02 (+0.36%)
At close: 04:00PM EST
5.60 +0.07 (+1.27%)
Pre-Market: 04:39AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close5.51
Open5.54
Bid0.00 x 3200
Ask0.00 x 3100
Day's Range5.49 - 5.67
52 Week Range1.82 - 7.80
Volume2,039,922
Avg. Volume3,092,446
Market Cap701.724M
Beta (5Y Monthly)0.86
PE Ratio (TTM)N/A
EPS (TTM)-1.23
Earnings DateMar 29, 2023 - Apr 03, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.41
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CTIC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CTI BioPharma Corp.
    Technical Assessment: Neutral in the Intermediate-Term"Well, well, well," said the Bear to the growing number of Bulls. "Not so fast." On Wednesday, another trip to the 200-day average by the S&P 500 (and almost to the bear-market trendline) ended at a large "Do Not Pass Go" sign. As many know, that sign also reads "Do Not Collect $200," in this case a reference to the 200-day average. The SPX gave back 1.6%, the Nasdaq shed 1.2%, and the QQQs dropped 1.3%. Both the S&P 400 and the Russell 2000 ran smack into chart resistance from their recent highs in November and December, and did a 180.
    Rating
    Fair Value
    Economic Moat
    13 days agoArgus Research
View more
Advertisement
Advertisement